Tuesday, April 10, 2018

BRIEF-GB Sciences Pursues FDA-Registered, First-In-Human Trial Of Cannabis Based Therapy For Parkinson's Disease

* COMPANY WILL BEGIN ITS TOXICOLOGY STUDIES IN SUMMER OF 2018 Source text for Eikon: Further company coverage:
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)